ARTL Earnings

Quarterly EPS
$-6.30
Q3 2024
$-7.89
Q4 2024
$-12.55
Q1 2025
$-16.86
Q2 2025
$-11.91
Q3 2025
$-4.24
Q4 2025
$-4.00
Q1 2026
$-0.89
Q2 2026
Latest RevenueN/A
Latest Net Income-2427000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.890-2427000+94.7%
Q1 2026-$4.000-2958000+68.1%
Q4 2025-$4.240-4166000+46.3%
Q3 2025-$11.910-3120000-89.0%
Q2 2025-$16.860-3221000-24.3%
Q1 2025-$12.550-2372000+10.6%
Q4 2024-$7.890-3778000+54.7%
Q3 2024-$6.300-1132000+57.8%
Q2 2024-$13.560-2433000
Q1 2024-$14.040-2483000
Q4 2023-$17.400-3073000
Q3 2023-$14.940-2449000
Artelo Biosciences (ARTL) — Earnings